[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mauri‐Obradors et al., 2018 - Google Patents

Benefits of non‐surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial

Mauri‐Obradors et al., 2018

View PDF
Document ID
6837242091356194704
Author
Mauri‐Obradors E
Merlos A
Estrugo‐Devesa A
Jané‐Salas E
López‐López J
Viñas M
Publication year
Publication venue
Journal of clinical periodontology

External Links

Snippet

Background Periodontitis and diabetes are highly prevalent conditions whose association has long been recognized. Objective To evaluate the effect of non‐surgical periodontal treatment on serum HbA1c (haemoglobin A1c or glycated haemoglobin) levels in patients …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Micro-organisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Similar Documents

Publication Publication Date Title
Mauri‐Obradors et al. Benefits of non‐surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial
Teles et al. Impact of systemic factors in shaping the periodontal microbiome
Invernici et al. Effects of Bifidobacterium probiotic on the treatment of chronic periodontitis: a randomized clinical trial
Al-Kamel et al. Subgingival microbiome of experimental gingivitis: shifts associated with the use of chlorhexidine and N-acetyl cysteine mouthwashes
Cameron et al. The human salivary microbiome exhibits temporal stability in bacterial diversity
Pushalkar et al. Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw
Miranda et al. Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1‐year outcomes of a randomized placebo‐controlled clinical trial
Meurman et al. Oral health, atherosclerosis, and cardiovascular disease
Hajishengallis The inflammophilic character of the periodontitis‐associated microbiota
Koromantzos et al. A randomized, controlled trial on the effect of non‐surgical periodontal therapy in patients with type 2 diabetes. Part I: effect on periodontal status and glycaemic control
Nibali et al. Gene polymorphisms and the prevalence of key periodontal pathogens
Guentsch et al. Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis
Wang et al. Analysis of oral microbial community and Th17‐associated cytokines in saliva of patients with oral lichen planus
Abusleme et al. Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis
George et al. Oral microbiota species in acute apical endodontic abscesses
Baek et al. Association of the invasion ability of Porphyromonas gingivalis with the severity of periodontitis
Vardar‐Sengul et al. Human β defensin‐1 and‐2 expression in the gingiva of patients with specific periodontal diseases
Lu et al. Microbiome in maintained periodontitis and its shift over a single maintenance interval of 3 months
Nadkarni et al. Pattern of distribution of Prevotella species/phylotypes associated with healthy gingiva and periodontal disease
Santos et al. Partial‐and full‐mouth scaling and root planing in type 2 diabetic subjects: a 12‐mo follow‐up of clinical parameters and levels of cytokines and osteoclastogenesis‐related factors
Al‐hebshi et al. Quantitative analysis of classical and new putative periodontal pathogens in subgingival biofilm: a case–control study
Joaquim et al. The combined and individual impact of diabetes and smoking on key subgingival periodontal pathogens in patients with chronic periodontitis
Sembler-Møller et al. Next-generation sequencing of whole saliva from patients with primary Sjögren’s syndrome and non-Sjögren’s sicca reveals comparable salivary microbiota
Wang et al. Relationship between expression of human gingival beta‐defensins and levels of periodontopathogens in subgingival plaque
Kinane et al. Experimental gingivitis, bacteremia and systemic biomarkers: a randomized clinical trial